Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Santen Pharmaceutical Co., Ltd.

Clinical trials sponsored by Santen Pharmaceutical Co., Ltd., explained in plain language.

Santen Pharmaceutical Co., Ltd. 4536 TOKYO

A Japanese pharmaceutical company specializing in ophthalmology.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet finished but already full! 1

New eye drop shows promise for glaucoma control in chinese patients

Disease control Ongoing

This study tests a new eye drop called DE-117B in 345 Chinese adults with open-angle glaucoma or high eye pressure. The goal is to see if it safely lowers eye pressure better than an existing drug. Participants use the drops once daily for at least 4 weeks, with long-term follow-…

Phase: PHASE3 • Sponsor: Santen Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 12:32 UTC